Testing effectiveness (Phase 2)WithdrawnNCT04535102What this trial is testingPOLA+BR for Relapsed or Refractory DLBCLWho this might be right forDiffuse Large B Cell Lymphoma University of Colorado, Denver
Early research (Phase 1)UnknownNCT04008251What this trial is testingHumanized CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaB Cell Lymphoma Wuhan Sian Medical Technology Co., Ltd 10
Early research (Phase 1)Not Yet RecruitingNCT07616089What this trial is testingPhase I Study of FXS0683 in the Treatment of Blood TumorsWho this might be right forB-Cell LymphomaAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 228
Testing effectiveness (Phase 2)Ended earlyNCT04161118What this trial is testingTisaGenlecleucel in Elderly Patients With First-Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma University of Cologne 3
Testing effectiveness (Phase 2)Ended earlyNCT06088654What this trial is testingPhase1/2 Study of IPH6501 in Patients With Relapsed /Refractory B-Cell Non-Hodgkin LymphomaWho this might be right forNon Hodgkin Lymphoma Innate Pharma 23
Not applicableStudy completedNCT07103486What this trial is testingEvaluate the Therapeutic Benefit of Tisagenlecleucel Compared to Existing Standard of Care in German Adult Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDiffuse Large B-Cell Lymphoma Novartis Pharmaceuticals 264
Testing effectiveness (Phase 2)Study completedNCT02207062What this trial is testingIbrutinib in Treating Patients With Relapsed or Refractory Transformed Indolent B-cell Non-Hodgkin LymphomaWho this might be right forRecurrent Transformed B-Cell Non-Hodgkin LymphomaRefractory Transformed B-Cell Non-Hodgkin Lymphoma University of Washington 20
Testing effectiveness (Phase 2)Study completedNCT00445341What this trial is testingFlavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)WithdrawnNCT03880279What this trial is testingAutologous TAC T Cells Targeting CD19 in R/R Large B-Cell LymphomaWho this might be right forLymphoma, B-Cell Triumvira Immunologics, Inc.
Early research (Phase 1)Active Not RecruitingNCT01695941What this trial is testingAlisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin LymphomaWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Mantle Cell LymphomaRefractory B-Cell Non-Hodgkin Lymphoma+1 more National Cancer Institute (NCI) 24
Large-scale testing (Phase 3)Looking for participantsNCT07479797What this trial is testingStudy Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line TherapyWho this might be right forRelapsed or Refractory Large B-cell Lymphoma Kite, A Gilead Company 550
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Very early researchLooking for participantsNCT06693973What this trial is testingAn Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Testing effectiveness (Phase 2)Looking for participantsNCT04502394What this trial is testingSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLLWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Kartos Therapeutics, Inc. 84
Early research (Phase 1)Study completedNCT03955783What this trial is testingVenetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic MalignanciesWho this might be right forDiffuse Large B-cell LymphomaAcute Myeloid LeukemiaNon-Hodgkin's Lymphoma Sanjay Mohan 78
Early research (Phase 1)UnknownNCT04684472What this trial is testingModified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell MalignanciesWho this might be right forRefractory B-Cell Non-Hodgkin LymphomaRefractory Leukemia Liqun Zou 18
Testing effectiveness (Phase 2)Study completedNCT03484702What this trial is testingTrial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-Hodgkin Celgene 113
Very early researchNot Yet RecruitingNCT04609241What this trial is testingCD79b CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia and B-cell Non-Hodgkin's LymphomaWho this might be right forRelapsed and/or Refractory Acute Lymphoblastic LeukemiaRelapsed and/or Refractory B-cell Non-Hodgkin's Lymphoma Zhejiang University 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07122609What this trial is testingPirtobrutinib in Combination With Rituximab, Gemcitabine, Oxaliplatin With or Without Polatuzumab Vedotin in Covalent BTK Inhibitor-Pretreated Relapsed/Refractory Diffuse Large B-Cell LymphomaWho this might be right forRelapsed and Refractory DLBCL Ruijin Hospital 22
Testing effectiveness (Phase 2)Study completedNCT01381692What this trial is testingBortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular LymphomaWho this might be right forRecurrent Follicular LymphomaRecurrent Mantle Cell LymphomaRecurrent Marginal Zone Lymphoma+8 more National Cancer Institute (NCI) 9